Triphenylphosphine
≥95.0% (GC)
Manufacturer: Sigma Aldrich
CAS Number: 603-35-0
Synonym(S): Phosphorustriphenyl
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 250 G | 93092-250-G | In Stock | ₹ 9,688.38 |
| 1 KG | 93092-1-KG | In Stock | ₹ 12,145.65 |
93092 - 250 G
In Stock
Quantity
1
Base Price: ₹ 9,688.38
GST (18%): ₹ 1,743.908
Total Price: ₹ 11,432.288
vapor density
9 (vs air)
Quality Level
200
vapor pressure
5 mmHg ( 20 °C)
Assay
≥95.0% (GC)
form
crystals
reaction suitability
reaction type: Buchwald-Hartwig Cross Coupling Reactionreaction type: Heck Reactionreaction type: Hiyama Couplingreaction type: Negishi Couplingreaction type: Sonogashira Couplingreaction type: Stille Couplingreaction type: Suzuki-Miyaura Couplingreagent type: ligand
impurities
~3% triphenylphosphine oxide
bp
377 °C (lit.)
mp
77-84 °C79-81 °C (lit.)
solubility
water: soluble 0.00017 g/L at 22 °C
Other Options
Related Products
Description
- General description: Triphenylphosphine, also referred to as PPH3, is an organophosphorous compound. It readily forms complexes with platinum-metal group salts.[1]
- Application: The palladium-based complexes bearing 1, 3-dibenzylbenzimidazolium with morpholine, triphenylphosphine, and pyridine derivate ligands: This study discusses the synthesis and characterization of new palladium-based complexes incorporating triphenylphosphine, providing insights into their potential catalytic activities (Aktaş et al., 2022). Polymer-supported triphenylphosphine: This review highlights the diverse applications of polymer-supported triphenylphosphine in organic synthesis and its significant role in promoting more sustainable and efficient chemical processes (Moussa et al., 2019). Application prospects of triphenylphosphine-based mitochondria-targeted cancer therapy: The review focuses on the utilization of triphenylphosphine for developing mitochondria-targeted drugs, emphasizing its potential in cancer therapy (Cheng et al., 2023).
SAFETY INFORMATION
Pictograms
Signal Word
Danger
Hazard Statements
Precautionary Statements
P260 - P280 - P301 + P312 - P302 + P352 - P305 + P351 + P338 - P314
Hazard Classifications
Acute Tox. 4 Oral - Eye Dam. 1 - Skin Sens. 1B - STOT RE 1 Inhalation
Target Organs
Central nervous system,Peripheral nervous system
WGK
WGK 2
Flash Point(F)
356.0 °F
Flash Point(C)
180 °C
Personal Protective Equipment
dust mask type N95 (US), Eyeshields, Gloves
Compare Similar Items
Show Difference
vapor density: 9 (vs air)
Quality Level: 200
vapor pressure: 5 mmHg ( 20 °C)
Assay: ≥95.0% (GC)
form: crystals
reaction suitability: reaction type: Buchwald-Hartwig Cross Coupling Reactionreaction type: Heck Reactionreaction type: Hiyama Couplingreaction type: Negishi Couplingreaction type: Sonogashira Couplingreaction type: Stille Couplingreaction type: Suzuki-Miyaura Couplingreagent type: ligand
impurities: ~3% triphenylphosphine oxide
bp: 377 °C (lit.)
mp: 77-84 °C79-81 °C (lit.)
solubility: water: soluble 0.00017 g/L at 22 °C
vapor density: __
Quality Level: 100
vapor pressure: __
Assay: __
form: solid
reaction suitability: reaction type: Buchwald-Hartwig Cross Coupling Reactionreaction type: Heck Reactionreaction type: Hiyama Couplingreaction type: Negishi Couplingreaction type: Sonogashira Couplingreaction type: Stille Couplingreaction type: Suzuki-Miyaura Couplingreaction type: solution phase peptide synthesisreagent type: ligand
impurities: __
bp: __
mp: __
solubility: __
vapor density: __
Quality Level: 100
vapor pressure: __
Assay: ≥99.9% trace metals basis
form: powder
reaction suitability: __
impurities: ≤0.5 wt. % H2O≤1000 ppm (trace metals analysis)
bp: __
mp: 264 °C (lit.)
solubility: H2O: soluble (highly soluble(lit.))acetone: soluble ((lit.))alcohols: soluble ((lit.))